<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Clin Cancer Res</journal-id>
        <journal-id journal-id-type="iso-abbrev">Clin. Cancer Res.</journal-id>
        <journal-id journal-id-type="pmc-domain-id">319</journal-id>
        <journal-id journal-id-type="pmc-domain">nihpa</journal-id>
        <journal-title-group>
          <journal-title>Clinical cancer research : an official journal of the American Association for Cancer Research</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">1078-0432</issn>
        <issn pub-type="epub">1557-3265</issn>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-is-collection-domain</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-collection-title</meta-name>
            <meta-value>NIHPA Author Manuscripts</meta-value>
          </custom-meta>
        </custom-meta-group>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC7367727</article-id>
        <article-id pub-id-type="pmcid-ver">PMC7367727.1</article-id>
        <article-id pub-id-type="pmcaid">7367727</article-id>
        <article-id pub-id-type="pmcaiid">7367727</article-id>
        <article-id pub-id-type="manuscript-id">NIHMS1580719</article-id>
        <article-id pub-id-type="pmid">32220886</article-id>
        <article-id pub-id-type="doi">10.1158/1078-0432.CCR-19-2563</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHMS1580719</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHPA1580719</article-id>
        <article-version article-version-type="pmc-version">1</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Article</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Whole-Exome Sequencing Analysis of the Progression from Non-Low Grade Ductal Carcinoma <italic toggle="yes">In Situ</italic> to Invasive Ductal Carcinoma</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Pareja</surname>
              <given-names initials="F">Fresia</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref rid="FN3" ref-type="author-notes">*</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Brown</surname>
              <given-names initials="DN">David N.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref rid="FN3" ref-type="author-notes">*</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Lee</surname>
              <given-names initials="JY">Ju Youn</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref rid="FN3" ref-type="author-notes">*</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Da Cruz Paula</surname>
              <given-names initials="A">Arnaud</given-names>
            </name>
            <xref ref-type="aff" rid="A2">2</xref>
            <xref rid="FN3" ref-type="author-notes">*</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Selenica</surname>
              <given-names initials="P">Pier</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Bi</surname>
              <given-names initials="R">Rui</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Geyer</surname>
              <given-names initials="FC">Felipe C.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Gazzo</surname>
              <given-names initials="A">Andrea</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>da Silva</surname>
              <given-names initials="EM">Edaise M.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Vahdatinia</surname>
              <given-names initials="M">Mahsa</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Stylianou</surname>
              <given-names initials="A">Anthe</given-names>
            </name>
            <xref ref-type="aff" rid="A2">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ferrando</surname>
              <given-names initials="L">Lorenzo</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A3">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Wen</surname>
              <given-names initials="HY">Hannah Y.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Hicks</surname>
              <given-names initials="JB">James B.</given-names>
            </name>
            <xref ref-type="aff" rid="A4">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Weigelt</surname>
              <given-names initials="B">Britta</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Reis-Filho</surname>
              <given-names initials="JS">Jorge S.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A5">5</xref>
          </contrib>
        </contrib-group>
        <aff id="A1"><label>1</label>Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY</aff>
        <aff id="A2"><label>2</label>Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY</aff>
        <aff id="A3"><label>3</label>Department of Internal Medicine, University of Genoa, Genova, Italy</aff>
        <aff id="A4"><label>4</label>Department of Biological Sciences, University of Southern California, Los Angeles, CA</aff>
        <aff id="A5"><label>5</label>Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY</aff>
        <author-notes>
          <fn fn-type="con" id="FN1">
            <p id="P1">AUTHORSâ€™ CONTRIBUTIONS</p>
            <p id="P2">JBH, BW and JSR-F conceived the study and supervised the work. FP and YHW provided samples. FP, RB, FCG, MV and YHW reviewed the cases. Sample processing was performed by FP, RB, EdS, MV and AS. Bioinformatics analysis was performed by DNB, JYL, ADCP, PS and AG. FP, DNB, JYL, ADCP, PS, AG and LF performed data analysis and data interpretation. FP and JYL wrote the first draft of the manuscript. All authors edited and approved the final draft.</p>
          </fn>
          <fn fn-type="equal" id="FN3">
            <label>*</label>
            <p id="P3">Equal contribution</p>
          </fn>
          <corresp id="CR1"><bold>Correspondence: Dr. Jorge S. Reis-Filho, MD PhD FRCPath</bold>, Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Phone: 212-639-8054. <email>reisfilj@mskcc.org</email>; and <bold>Dr. Britta Weigelt, PhD</bold>, Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Phone: 212-639-2332. <email>weigeltb@mskcc.org</email></corresp>
          <fn fn-type="COI-statement" id="FN4">
            <p id="P43">CONFLICTS OF INTEREST</p>
            <p id="P44">JSR-F reports personal/consultancy fees from VolitionRx, Page.AI, Goldman Sachs, Grail, REPARE Therapeutics, Ventana Medical Systems, InVicro, Roche Diagnostics and Genentech, outside the scope of the submitted work. All other authors declare no conflicts of interest.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="epub">
          <day>27</day>
          <month>3</month>
          <year>2020</year>
        </pub-date>
        <pub-date pub-type="ppub">
          <day>15</day>
          <month>7</month>
          <year>2020</year>
        </pub-date>
        <volume>26</volume>
        <issue>14</issue>
        <issue-id pub-id-type="pmc-issue-id">361678</issue-id>
        <fpage>3682</fpage>
        <lpage>3693</lpage>
        <pub-history>
          <event event-type="nihms-submitted">
            <date>
              <day>09</day>
              <month>04</month>
              <year>2020</year>
            </date>
          </event>
          <event event-type="pmc-release">
            <date>
              <day>15</day>
              <month>01</month>
              <year>2021</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>15</day>
              <month>01</month>
              <year>2021</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2024-06-16 17:25:13.873">
              <day>16</day>
              <month>06</month>
              <year>2024</year>
            </date>
          </event>
        </pub-history>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1580719.pdf"/>
        <abstract id="ABS1">
          <sec id="S1">
            <title>Purpose:</title>
            <p id="P4">Ductal carcinoma <italic toggle="yes">in situ</italic> (DCIS) is a non-obligate precursor of invasive breast cancer. Here, we sought to investigate the level of intra-lesion genetic heterogeneity in DCIS and the patterns of clonal architecture changes in the progression from DCIS to invasive disease.</p>
          </sec>
          <sec id="S2">
            <title>Design:</title>
            <p id="P5">Synchronous DCIS (n=27) and invasive ductal carcinomas of no special type (IDC-NSTs; n=26) from 25 patients and pure DCIS (n=7) from 7 patients were microdissected separately and subjected to high-depth whole-exome (n=56) or massively parallel sequencing targeting â‰¥410 key cancer-related genes (n=4). Somatic genetic alterations, mutational signatures, clonal composition and phylogenetic analyses were defined using validated computational methods.</p>
          </sec>
          <sec id="S3">
            <title>Results:</title>
            <p id="P6">DCIS revealed genetic alterations similar to those of synchronously diagnosed IDC-NSTs and of non-related IDC-NSTs from The Cancer Genome Atlas (TCGA), whereas pure DCIS lacked <italic toggle="yes">PIK3CA</italic> mutations. Clonal decomposition and phylogenetic analyses based on somatic mutations and copy number alterations revealed that the mechanisms of progression of DCIS to invasive carcinoma are diverse, and that clonal selection might have constituted the mechanism of progression from DCIS to invasive disease in 28% (7/25) of patients. DCIS displaying a pattern of clonal selection in the progression to invasive cancer harbored higher levels of intra-lesion genetic heterogeneity than DCIS where no clonal selection was observed.</p>
          </sec>
          <sec id="S4">
            <title>Conclusions:</title>
            <p id="P7">Intra-lesion genetic heterogeneity is a common feature in DCIS synchronously diagnosed with IDC-NST. DCIS is a non-obligate precursor of IDC-NST, whose mechanisms of progression to invasive breast cancer are diverse and vary from case to case.</p>
          </sec>
        </abstract>
        <kwd-group>
          <kwd>ductal carcinoma <italic toggle="yes">in situ</italic></kwd>
          <kwd>invasive ductal carcinoma</kwd>
          <kwd>whole-exome sequencing</kwd>
          <kwd>clonal decomposition</kwd>
          <kwd>non-obligate precursor</kwd>
          <kwd>clonal relatedness</kwd>
          <kwd>progression</kwd>
        </kwd-group>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
  </article>
</pmc-articleset>
